AirSculpt Technologies (AIRS) Competitors

$4.49 -0.11 (-2.39%)

As of 03:10 PM Eastern

AIRS vs. ARDT, AHCO, TDOC, CDNA, and INNV

Should you buy AirSculpt Technologies stock or one of its competitors? MarketBeat compares AirSculpt Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AirSculpt Technologies include Ardent Health (ARDT), AdaptHealth (AHCO), Teladoc Health (TDOC), CareDx (CDNA), and InnovAge (INNV). These companies are all part of the "healthcare" industry.

How does AirSculpt Technologies compare to Ardent Health?

Ardent Health (NYSE:ARDT) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Ardent Health has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.22	$135.81M	$0.95	10.04
AirSculpt Technologies	$151.84M	2.09	-$11.67M	-$0.17	N/A

In the previous week, Ardent Health had 2 more articles in the media than AirSculpt Technologies. MarketBeat recorded 2 mentions for Ardent Health and 0 mentions for AirSculpt Technologies. Ardent Health's average media sentiment score of 0.51 beat AirSculpt Technologies' score of 0.00 indicating that Ardent Health is being referred to more favorably in the media.

Company	Overall Sentiment
Ardent Health	Positive
AirSculpt Technologies	Neutral

91.5% of AirSculpt Technologies shares are held by institutional investors. 1.9% of Ardent Health shares are held by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Ardent Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.31, indicating that its stock price is 131% more volatile than the broader market.

Ardent Health has a net margin of 2.09% compared to AirSculpt Technologies' net margin of -7.39%. Ardent Health's return on equity of 13.85% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

Ardent Health currently has a consensus target price of $14.21, suggesting a potential upside of 49.01%. AirSculpt Technologies has a consensus target price of $4.50, suggesting a potential upside of 0.22%. Given Ardent Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Ardent Health is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Ardent Health beats AirSculpt Technologies on 12 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to AdaptHealth?

AirSculpt Technologies (NASDAQ:AIRS) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

AdaptHealth has a net margin of -2.42% compared to AirSculpt Technologies' net margin of -7.39%. AdaptHealth's return on equity of 2.76% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
AdaptHealth	-2.42%	2.76%	0.99%

AirSculpt Technologies has higher earnings, but lower revenue than AdaptHealth. AirSculpt Technologies is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.84M	2.09	-$11.67M	-$0.17	N/A
AdaptHealth	$3.24B	0.41	-$70.79M	-$0.62	N/A

In the previous week, AdaptHealth's average media sentiment score of 0.67 beat AirSculpt Technologies' score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
AirSculpt Technologies	Neutral
AdaptHealth	Positive

AirSculpt Technologies has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market.

AirSculpt Technologies presently has a consensus price target of $4.50, indicating a potential upside of 0.22%. AdaptHealth has a consensus price target of $14.29, indicating a potential upside of 44.37%. Given AdaptHealth's stronger consensus rating and higher possible upside, analysts plainly believe AdaptHealth is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

AdaptHealth beats AirSculpt Technologies on 9 of the 15 factors compared between the two stocks.

How does AirSculpt Technologies compare to Teladoc Health?

AirSculpt Technologies (NASDAQ:AIRS) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

AirSculpt Technologies has a beta of 2.31, indicating that its stock price is 131% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market.

In the previous week, Teladoc Health had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 3 mentions for Teladoc Health and 0 mentions for AirSculpt Technologies. Teladoc Health's average media sentiment score of 1.28 beat AirSculpt Technologies' score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Overall Sentiment
AirSculpt Technologies	Neutral
Teladoc Health	Positive

AirSculpt Technologies currently has a consensus target price of $4.50, suggesting a potential upside of 0.22%. Teladoc Health has a consensus target price of $7.43, suggesting a potential downside of 4.52%. Given AirSculpt Technologies' higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24

AirSculpt Technologies has higher earnings, but lower revenue than Teladoc Health. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.84M	2.09	-$11.67M	-$0.17	N/A
Teladoc Health	$2.53B	0.56	-$200.32M	-$0.97	N/A

Teladoc Health has a net margin of -6.81% compared to AirSculpt Technologies' net margin of -7.39%. AirSculpt Technologies' return on equity of -4.98% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Teladoc Health	-6.81%	-11.45%	-5.54%

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

AirSculpt Technologies beats Teladoc Health on 9 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to CareDx?

CareDx (NASDAQ:CDNA) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

CareDx currently has a consensus target price of $25.00, suggesting a potential downside of 5.32%. AirSculpt Technologies has a consensus target price of $4.50, suggesting a potential upside of 0.22%. Given AirSculpt Technologies' higher probable upside, analysts plainly believe AirSculpt Technologies is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, CareDx had 5 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for CareDx and 0 mentions for AirSculpt Technologies. CareDx's average media sentiment score of 0.36 beat AirSculpt Technologies' score of 0.00 indicating that CareDx is being referred to more favorably in the media.

Company	Overall Sentiment
CareDx	Neutral
AirSculpt Technologies	Neutral

91.5% of AirSculpt Technologies shares are owned by institutional investors. 2.4% of CareDx shares are owned by company insiders. Comparatively, 44.6% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CareDx has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.31, meaning that its stock price is 131% more volatile than the broader market.

AirSculpt Technologies has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than AirSculpt Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	3.59	-$21.35M	-$0.16	N/A
AirSculpt Technologies	$151.84M	2.09	-$11.67M	-$0.17	N/A

CareDx has a net margin of -2.01% compared to AirSculpt Technologies' net margin of -7.39%. CareDx's return on equity of -2.65% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

Summary

CareDx beats AirSculpt Technologies on 11 of the 16 factors compared between the two stocks.

How does AirSculpt Technologies compare to InnovAge?

InnovAge (NASDAQ:INNV) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

InnovAge has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market.

In the previous week, InnovAge's average media sentiment score of 0.00 equaled AirSculpt Technologies'average media sentiment score.

Company	Overall Sentiment
InnovAge	Neutral
AirSculpt Technologies	Neutral

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 1.0% of InnovAge shares are owned by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

InnovAge presently has a consensus price target of $7.00, suggesting a potential downside of 27.08%. AirSculpt Technologies has a consensus price target of $4.50, suggesting a potential upside of 0.22%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

AirSculpt Technologies has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than AirSculpt Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.53	-$30.31M	-$0.09	N/A
AirSculpt Technologies	$151.84M	2.09	-$11.67M	-$0.17	N/A

InnovAge has a net margin of -1.22% compared to AirSculpt Technologies' net margin of -7.39%. InnovAge's return on equity of -4.73% beat AirSculpt Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

Summary

AirSculpt Technologies beats InnovAge on 8 of the 13 factors compared between the two stocks.

Get AirSculpt Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIRS vs. The Competition

Export

Metric	AirSculpt Technologies	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$317.81M	$4.15B	$6.63B	$12.22B
Dividend Yield	N/A	2.12%	3.22%	5.82%
P/E Ratio	-26.50	39.24	27.53	24.00
Price / Sales	2.09	46.19	391.99	120.01
Price / Cash	265.66	38.28	23.20	54.51
Price / Book	3.21	4.48	5.69	6.44
Net Income	-$11.67M	$31.97M	$204.76M	$337.14M
7 Day Performance	-6.65%	-2.62%	5.09%	-0.36%
1 Month Performance	-15.76%	-4.62%	-0.38%	0.61%
1 Year Performance	-12.65%	18.65%	28.01%	27.86%

AirSculpt Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIRS AirSculpt Technologies	1.1448 of 5 stars	$4.49 -2.4%	$4.50 +0.2%	-5.2%	$317.81M	$151.84M	N/A	240
ARDT Ardent Health	4.2278 of 5 stars	$9.30 -2.1%	$14.21 +52.8%	-29.1%	$1.36B	$6.32B	9.79	25,200	High Trading Volume
AHCO AdaptHealth	4.6039 of 5 stars	$10.14 +1.8%	$14.29 +40.9%	+16.9%	$1.35B	$3.24B	N/A	10,900
TDOC Teladoc Health	1.2746 of 5 stars	$7.58 +1.5%	$7.43 -1.9%	-2.8%	$1.35B	$2.53B	N/A	5,600	Positive News
CDNA CareDx	1.6544 of 5 stars	$23.25 -3.4%	$25.00 +7.5%	+32.6%	$1.24B	$379.80M	N/A	740

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIRS) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AirSculpt Technologies (AIRS) Competitors

AIRS vs. ARDT, AHCO, TDOC, CDNA, and INNV

How does AirSculpt Technologies compare to Ardent Health?

Summary

How does AirSculpt Technologies compare to AdaptHealth?

Summary

How does AirSculpt Technologies compare to Teladoc Health?

Summary

How does AirSculpt Technologies compare to CareDx?

Summary

How does AirSculpt Technologies compare to InnovAge?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIRS vs. The Competition

AirSculpt Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AirSculpt Technologies (AIRS) Competitors

AIRS vs. ARDT, AHCO, TDOC, CDNA, and INNV

How does AirSculpt Technologies compare to Ardent Health?

Which has higher valuation and earnings, ARDT or AIRS?

Does the media prefer ARDT or AIRS?

Do insiders & institutionals hold more shares of ARDT or AIRS?

Which has more volatility & risk, ARDT or AIRS?

Is ARDT or AIRS more profitable?

Do analysts prefer ARDT or AIRS?

Summary

How does AirSculpt Technologies compare to AdaptHealth?

Is AIRS or AHCO more profitable?

Which has preferable valuation and earnings, AIRS or AHCO?

Does the media refer more to AIRS or AHCO?

Which has more volatility & risk, AIRS or AHCO?

Do analysts prefer AIRS or AHCO?

Do insiders & institutionals believe in AIRS or AHCO?

Summary

How does AirSculpt Technologies compare to Teladoc Health?

Which has more volatility and risk, AIRS or TDOC?

Does the media favor AIRS or TDOC?

Do analysts prefer AIRS or TDOC?

Which has preferable earnings and valuation, AIRS or TDOC?

Is AIRS or TDOC more profitable?

Do institutionals & insiders have more ownership in AIRS or TDOC?

Summary

How does AirSculpt Technologies compare to CareDx?

Do analysts rate CDNA or AIRS?

Does the media prefer CDNA or AIRS?

Do insiders and institutionals hold more shares of CDNA or AIRS?

Which has more risk and volatility, CDNA or AIRS?

Which has preferable valuation & earnings, CDNA or AIRS?

Is CDNA or AIRS more profitable?

Summary

How does AirSculpt Technologies compare to InnovAge?

Which has more volatility and risk, INNV or AIRS?

Does the media prefer INNV or AIRS?

Do institutionals & insiders hold more shares of INNV or AIRS?

Do analysts rate INNV or AIRS?

Which has stronger earnings and valuation, INNV or AIRS?

Is INNV or AIRS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIRS vs. The Competition

AirSculpt Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools